Within blood cancers, although there are several studies that have identified a potent role of deregulated MARCKS with the overall process of carcinogenesis [14–18], yet our overall understanding of the regulatory roles of the gene and the associated protein remains at a nascent stage. Here, MARCKS is linked to hematopoietic and lymphoid system neoplasm.